請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/8622
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 賈景山(Jean-san Chia) | |
dc.contributor.author | Ching-Ning Haung | en |
dc.contributor.author | 黃靖甯 | zh_TW |
dc.date.accessioned | 2021-05-20T19:59:01Z | - |
dc.date.available | 2015-09-09 | |
dc.date.available | 2021-05-20T19:59:01Z | - |
dc.date.copyright | 2010-09-09 | |
dc.date.issued | 2010 | |
dc.date.submitted | 2010-07-01 | |
dc.identifier.citation | 參考文獻
行政院衛生署食品衛生處。2007。健康食品之輔助調整過敏體質功能評估方法 王豐洲,1972。黃豆之加工利用。食品工業。04(09):3-8 朱家瑜,2007。異位性皮膚炎。 青山敏明,1999。大豆 蛋白質 大豆 生理機能研究。食品 開發. 34(7): 15-17 潘文雄,1996。發酵物妙用多。元氣齋出版社。台北。 康健雜誌,過敏專刊,2009 台大醫院小兒科衛教資訊,蔡紋如醫師,2005 Adachi, Y., Okazaki, M., Ohno, N., and Yadomae, T. (1994). Enhancement of cytokine production by macrophages stimulated wiTh (1-->3)-beta-D-glucan, grifolan (GRN), isolated from Grifola frondosa. Biol Pharm Bull 17, 1554-1560. Appleman, L.J., and Boussiotis, V.A. (2003). T cell anergy and costimulation. Immunol Rev 192, 161-180. Barone, K.S., Jain, S.L., and Michael, J.G. (1995). Effect of in vivo depletion of CD4+ and CD8+ cells on The induction and maintenance of oral tolerance. Cell Immunol 163, 19-29. Barnetson, R.S., and Rogers, M. (2002). Childhood atopic eczema. BMJ 324, 1376-1379. Benyacoub, J., Rochat, F., Saudan, K.Y., Rochat, I., Antille, N., Cherbut, C., von der Weid, T., Schiffrin, E.J., and Blum, S. (2008). Feeding a diet containing a fructooligosaccharide mix can enhance Salmonella vaccine efficacy in mice. J Nutr 138, 123-129. Blum, S., Alvarez, S., Haller, D., Perez, P., and Schiffrin, E.J. (1999). Intestinal microflora and The interaction wiTh immunocompetent cells. Antonie Van Leeuwenhoek 76, 199-205. Boguniewicz, M., and Leung, D.Y. Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol 125, 4-13; quiz 14-15. Brandtzaeg, P.E. (2002). Current understanding of gastrointestinal immunoregulation and its relation to food allergy. Ann N Y Acad Sci 964, 13-45. Breuer, K., Wittmann, M., Bosche, B., Kapp, A., and Werfel, T. (2000). Severe atopic dermatitis is associated wiTh sensitization to staphylococcal enterotoxin B (SEB). Allergy 55, 551-555. Brown, G.D., Herre, J., Williams, D.L., Willment, J.A., Marshall, A.S., and Gordon, S. (2003). Dectin-1 mediates The biological effects of beta-glucans. J Exp Med 197, 1119-1124. Benyacoub, J., Rochat, F., Saudan, K.Y., Rochat, I., Antille, N., Cherbut, C., von der Weid, T., Schiffrin, E.J., and Blum, S. (2008). Feeding a diet containing a fructooligosaccharide mix can enhance Salmonella vaccine efficacy in mice. J Nutr 138, 123-129. Campbell, J.M., Fahey, G.C., Jr., and Wolf, B.W. (1997). Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH and microflora in rats. J Nutr 127, 130-136. Cardona, I.D., Goleva, E., Ou, L.S., and Leung, D.Y. (2006). Staphylococcal enterotoxin B inhibits regulatory T cells by inducing glucocorticoid-induced TNF receptor-related protein ligand on monocytes. J Allergy Clin Immunol 117, 688-695. Chan, S.C., and Hanifin, J.M. (1993). Immunopharmacologic aspects of atopic dermatitis. Clin Rev Allergy 11, 523-541. Chehade, M., and Mayer, L. (2005). Oral tolerance and its relation to food hypersensitivities. J Allergy Clin Immunol 115, 3-12; quiz 13. Cho, S.H., Strickland, I., Boguniewicz, M., and Leung, D.Y. (2001a). Fibronectin and fibrinogen contribute to The enhanced binding of Staphylococcus aureus to atopic skin. J Allergy Clin Immunol 108, 269-274. Cho, S.H., Strickland, I., Tomkinson, A., Fehringer, A.P., Gelfand, E.W., and Leung, D.Y. (2001b). Preferential binding of Staphylococcus aureus to skin sites of Th2-mediated inflammation in a murine model. J Invest Dermatol 116, 658-663. Chen, H.-M., Muramoto, K. and Yamauchi, F., 1995, Structural analysis of antioxidative peptides from soybean β-conglycinin. J. Agric. Food Chem., 43: 574-578 Chen, Y., Inobe, J., Marks, R., Gonnella, P., Kuchroo, V.K., and Weiner, H.L. (1995a). Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376, 177-180. Chen, Y., Inobe, J., and Weiner, H.L. (1995b). Induction of oral tolerance to myelin basic protein in CD8-depleted mice: boTh CD4+ and CD8+ cells mediate active suppression. J Immunol 155, 910-916. Choi, Y.H., Lim, H., Heo, M.Y., Kwon, D.Y., and Kim, H.P. (2008). Anti-inflammatory activity of The eThanol extract of Chungkukjang, Korean fermented bean: 5-lipoxygenase inhibition. J Med Food 11, 539-543. Commane, D.M., Shortt, C.T., Silvi, S., Cresci, A., Hughes, R.M., and Rowland, I.R. (2005). Effects of fermentation products of pro- and prebiotics on trans-epiThelial electrical resistance in an in vitro model of The colon. Nutr Cancer 51, 102-109. de Vrese, M., and Schrezenmeir, J. (2008). Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol 111, 1-66. Doull, I.J., Campbell, M.J., and Holgate, S.T. (1998). Duration of growTh suppressive effects of regular inhaled corticosteroids. Arch Dis Child 78, 172-173. Du, Z., Kelly, E., Mecklenbrauker, I., Agle, L., Herrero, C., Paik, P., and Ivashkiv, L.B. (2006). Selective regulation of IL-10 signaling and function by zymosan. J Immunol 176, 4785-4792. Ebine, H., 1986, Fermented soy bean milk and oTher fermented legume milk products. In Reddy, N. R., Pierson, M. D. and Salunkhe, D. K. (eds.), “Legume-based fermented foods.” CRC Press, Boca Ration, Florida, U.S.A. pp. 47-68. Esaki, H., Nohara, Y., Onozaki, H., and Osawa, T., 1990, Antioxidative activity of natto. Nippon Shokuhin Kogyo Gakkaishi, 37. 474-477. Fartasch, M. (1997). Epidermal barrier in disorders of The skin. Microsc Res Tech 38, 361-372. Forrest, S., Dunn, K., Elliott, K., Fitzpatrick, E., Fullerton, J., McCarThy, M., Brown, J., Hill, D., and Williamson, R. (1999). Identifying genes predisposing to atopic eczema. J Allergy Clin Immunol 104, 1066-1070. Frias, J., Song, Y.S., Martinez-Villaluenga, C., Gonzalez de Mejia, E., and Vidal-Valverde, C. (2008). Immunoreactivity and amino acid content of fermented soybean products. J Agric Food Chem 56, 99-105. Friedman, A., and Weiner, H.L. (1994). Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci U S A 91, 6688-6692. Fujioka, N., Morimoto, Y., Arai, T., and Kikuchi, M. (2004). Discrimination between normal and malignant human gastric tissues by Fourier transform infrared spectroscopy. Cancer Detect Prev 28, 32-36. Fuller, R. (1991). Probiotics in human medicine. Gut 32, 439-442. Garside, P., Steel, M., Liew, F.Y., and Mowat, A.M. (1995). CD4+ but not CD8+ T cells are required for The induction of oral tolerance. Int Immunol 7, 501-504. Geha, R.S. (2003). Allergy and hypersensitivity. Nature versus nurture in allergy and hypersensitivity. Curr Opin Immunol 15, 603-608. Gibson, G.R., and Roberfroid, M.B. (1995). Dietary modulation of The human colonic microbiota: introducing The concept of prebiotics. J Nutr 125, 1401-1412. Girolomoni, G., and Pastore, S. (2001). The role of keratinocytes in The paThogenesis of atopic dermatitis. J Am Acad Dermatol 45, S25-28. Gombert, M., Dieu-Nosjean, M.C., Winterberg, F., Bunemann, E., Kubitza, R.C., Da Cunha, L., Haahtela, A., Lehtimaki, S., Muller, A., Rieker, J., et al. (2005). CCL1-CCR8 interactions: an axis mediating The recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation. J Immunol 174, 5082-5091. Hamilton-Miller, J.M. (2004). Probiotics and prebiotics in The elderly. Postgrad Med J 80, 447-451. Hattori, T., Ohishi, H., Yokota, T., Ohoami, H. and Watanabe, K., 1995, Antioxidative effect of crude antioxidant preparation from soybean fermented by Bacillus natto. Lebensm.-Wissh. U.- Technol., 28. 135-138. Hanifin, J.M., Chan, S.C., Cheng, J.B., Tofte, S.J., Henderson, W.R., Jr., Kirby, D.S., and Weiner, E.S. (1996). Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis. J Invest Dermatol 107, 51-56. Hawrylowicz, C.M., and O'Garra, A. (2005). Potential role of interleukin-10-secreting regulatory T cells in allergy and asThma. Nat Rev Immunol 5, 271-283. Hessle, C., Hanson, L.A., and Wold, A.E. (1999). Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production. Clin Exp Immunol 116, 276-282. Higgins, P.J., and Weiner, H.L. (1988). Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J Immunol 140, 440-445. Howell, M.D., Jones, J.F., Kisich, K.O., Streib, J.E., Gallo, R.L., and Leung, D.Y. (2004). Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum. J Immunol 172, 1763-1767. Hochstetter, R., Dobos, G., Kimmig, D., Dulkys, Y., Kapp, A., and Elsner, J. (2000). The CC chemokine receptor 3 CCR3 is functionally expressed on eosinophils but not on neutrophils. Eur J Immunol 30, 2759-2764. Humen, M.A., De Antoni, G.L., Benyacoub, J., Costas, M.E., Cardozo, M.I., Kozubsky, L., Saudan, K.Y., Boenzli-Bruand, A., Blum, S., Schiffrin, E.J., et al. (2005). Lactobacillus johnsonii La1 antagonizes Giardia intestinalis in vivo. Infect Immun 73, 1265-1269. Isolauri, E. (1997). Intestinal involvement in atopic disease. J R Soc Med 90 Suppl 30, 15-20. Isolauri, E. (2001a). Probiotics in human disease. Am J Clin Nutr 73, 1142S-1146S. Isolauri, E. (2001b). Probiotics in The prevention and treatment of allergic disease. Pediatr Allergy Immunol 12 Suppl 14, 56-59. Jung, T., and Stingl, G. (2008). Atopic dermatitis: Therapeutic concepts evolving from new paThophysiologic insights. J Allergy Clin Immunol 122, 1074-1081. Kalliomaki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P., and Isolauri, E. (2001). Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357, 1076-1079. Kapp, A. (1993). The role of eosinophils in The paThogenesis of atopic dermatitis--eosinophil granule proteins as markers of disease activity. Allergy 48, 1-5. Kim, K.H., Han, J.H., Chung, J.H., Cho, K.H., and Eun, H.C. (2006). Role of staphylococcal superantigen in atopic dermatitis: influence on keratinocytes. J Korean Med Sci 21, 315-323. Kullen, M.J., and Bettler, J. (2005). The delivery of probiotics and prebiotics to infants. Curr Pharm Des 11, 55-74. Leiferman, K.M., Ackerman, S.J., Sampson, H.A., Haugen, H.S., Venencie, P.Y., and Gleich, G.J. (1985). Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison wiTh onchocerciasis. N Engl J Med 313, 282-285. Leung, D.Y., and Bieber, T. (2003). Atopic dermatitis. Lancet 361, 151-160. Leung, D.Y., Harbeck, R., Bina, P., Reiser, R.F., Yang, E., Norris, D.A., Hanifin, J.M., and Sampson, H.A. (1993). Presence of IgE antibodies to staphylococcal exotoxins on The skin of patients wiTh atopic dermatitis. Evidence for a new group of allergens. J Clin Invest 92, 1374-1380. Leyden, J.J., and Kligman, A.M. (1977). The case for steroid--antibiotic combinations. Br J Dermatol 96, 179-187. Leyden, J.J., Marples, R.R., and Kligman, A.M. (1974). Staphylococcus aureus in The lesions of atopic dermatitis. Br J Dermatol 90, 525-530. Lin, Y.L., Lee, S.S., Hou, S.M., and Chiang, B.L. (2006). Polysaccharide purified from Ganoderma lucidum induces gene expression changes in human dendritic cells and promotes T helper 1 immune response in BALB/c mice. Mol Pharmacol 70, 637-644. MarTh, T., Zeitz, Z., Ludviksson, B., Strober, W., and Kelsall, B. (1998). Murine model of oral tolerance. Induction of Fas-mediated apoptosis by blockade of interleukin-12. Ann N Y Acad Sci 859, 290-294. Mayer, L., and Shao, L. (2004). Therapeutic potential of oral tolerance. Nat Rev Immunol 4, 407-419. Mercenier, A., Pavan, S., and Pot, B. (2003). Probiotics as bioTherapeutic agents: present knowledge and future prospects. Curr Pharm Des 9, 175-191. Messina, M.J., Persky, V., Setchell, K.D., and Barnes, S. (1994). Soy intake and cancer risk: a review of The in vitro and in vivo data. Nutr Cancer 21, 113-131. Miettinen, M., Matikainen, S., Vuopio-Varkila, J., Pirhonen, J., Varkila, K., Kurimoto, M., and Julkunen, I. (1998). Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells. Infect Immun 66, 6058-6062. Morar, N., Cookson, W.O., Harper, J.I., and Moffatt, M.F. (2007). Filaggrin mutations in children wiTh severe atopic dermatitis. J Invest Dermatol 127, 1667-1672. Moore, K.W., de Waal Malefyt, R., Coffman, R.L., and O'Garra, A. (2001). Interleukin-10 and The interleukin-10 receptor. Annu Rev Immunol 19, 683-765. Mucida, D., Kutchukhidze, N., Erazo, A., Russo, M., Lafaille, J.J., and Curotto de Lafaille, M.A. (2005). Oral tolerance in The absence of naturally occurring Tregs. J Clin Invest 115, 1923-1933. Nagata, S., McKenzie, C., Pender, S.L., Bajaj-Elliott, M., Fairclough, P.D., Walker-SmiTh, J.A., Monteleone, G., and MacDonald, T.T. (2000). Human Peyer's patch T cells are sensitized to dietary antigen and display a Th cell type 1 cytokine profile. J Immunol 165, 5315-5321. Nagler-Anderson, C., Bober, L.A., Robinson, M.E., Siskind, G.W., and Thorbecke, G.J. (1986). Suppression of type II collagen-induced arThritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci U S A 83, 7443-7446. Nagura, T., Hachimura, S., Hashiguchi, M., Ueda, Y., Kanno, T., Kikuchi, H., Sayama, K., and Kaminogawa, S. (2002). Suppressive effect of dietary raffinose on T-helper 2 cell-mediated immunity. Br J Nutr 88, 421-426. Nomura, T., Sandilands, A., Akiyama, M., Liao, H., Evans, A.T., Sakai, K., Ota, M., Sugiura, H., Yamamoto, K., Sato, H., et al. (2007). Unique mutations in The filaggrin gene in Japanese patients wiTh ichThyosis vulgaris and atopic dermatitis. J Allergy Clin Immunol 119, 434-440. Novak, N., Bieber, T., and Leung, D.Y. (2003). Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol 112, S128-139. Nussenblatt, R.B., Caspi, R.R., Mahdi, R., Chan, C.C., Roberge, F., Lider, O., and Weiner, H.L. (1990). Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance wiTh S-antigen. J Immunol 144, 1689-1695. O'Garra, A., Barrat, F.J., Castro, A.G., Vicari, A., and Hawrylowicz, C. (2008). Strategies for use of IL-10 or its antagonists in human disease. Immunol Rev 223, 114-131. O'Garra, A., and Vieira, P. (2004). Regulatory T cells and mechanisms of immune system control. Nat Med 10, 801-805. Olson, E.J., Standing, J.E., Griego-Harper, N., Hoffman, O.A., and Limper, A.H. (1996). Fungal beta-glucan interacts wiTh vitronectin and stimulates tumor necrosis factor alpha release from macrophages. Infect Immun 64, 3548-3554. Palframan, R., Gibson, G.R., and Rastall, R.A. (2003). Development of a quantitative tool for The comparison of The prebiotic effect of dietary oligosaccharides. Lett Appl Microbiol 37, 281-284. Palmer, C.N., Irvine, A.D., Terron-Kwiatkowski, A., Zhao, Y., Liao, H., Lee, S.P., Goudie, D.R., Sandilands, A., Campbell, L.E., SmiTh, F.J., et al. (2006). Common loss-of-function variants of The epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38, 441-446. Pastore, S., Fanales-Belasio, E., Albanesi, C., Chinni, L.M., Giannetti, A., and Girolomoni, G. (1997). Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in The skin. J Clin Invest 99, 3009-3017. Perdigon, G., Rachid, M., De Budeguer, M.V., and Valdez, J.C. (1994). Effect of yogurt feeding on The small and large intestine associated lymphoid cells in mice. J Dairy Res 61, 553-562. Peron, J.P., de Oliveira, A.P., and Rizzo, L.V. (2009). It takes guts for tolerance: The phenomenon of oral tolerance and The regulation of autoimmune response. Autoimmun Rev 9, 1-4. Reddy, N.R., Pierson, M.D., SaThe, S.K., and Salunkhe, D.K. (1982). Legume-based fermented foods: Their preparation and nutritional quality. Crit Rev Food Sci Nutr 17, 335-370. Roncarolo, M.G., Gregori, S., Battaglia, M., Bacchetta, R., Fleischhauer, K., and Levings, M.K. (2006). Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 212, 28-50. RoThe, M.J., and Grant-Kels, J.M. (1996). Atopic dermatitis: an update. J Am Acad Dermatol 35, 1-13; quiz 14-16. Saraiva, M., and O'Garra, A. (2010). The regulation of IL-10 production by immune cells. Nat Rev Immunol 10, 170-181. Saito, K., Yajima, T., Nishimura, H., Aiba, K., Ishimitsu, R., Matsuguchi, T., Fushimi, T., Ohshima, Y., Tsukamoto, Y., and Yoshikai, Y. (2003). Soluble branched beta-(1,4)glucans from Acetobacter species show strong activities to induce interleukin-12 in vitro and inhibit T-helper 2 cellular response wiTh immunoglobulin E production in vivo. J Biol Chem 278, 38571-38578. Sakai, K., Fujii, N., and Chukeatirote, E. (2006). Racemization of l-lactic acid in pH-swing open fermentation of kitchen refuse by selective proliferation of Lactobacillus plantarum. J Biosci Bioeng 102, 227-232. Sampson, H.A. (2003). The evaluation and management of food allergy in atopic dermatitis. Clin Dermatol 21, 183-192. Sanderson, I.R. (2007). Dietary modulation of GALT. J Nutr 137, 2557S-2562S. Simon, D., BraaThen, L.R., and Simon, H.U. (2004). Eosinophils and atopic dermatitis. Allergy 59, 561-570. Spanhaak, S., Havenaar, R., and Schaafsma, G. (1998). The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on The intestinal microflora and immune parameters in humans. Eur J Clin Nutr 52, 899-907. Spergel, J.M., Mizoguchi, E., Brewer, J.P., Martin, T.R., Bhan, A.K., and Geha, R.S. (1998). Epicutaneous sensitization wiTh protein antigen induces localized allergic dermatitis and hyperresponsiveness to meThacholine after single exposure to aerosolized antigen in mice. J Clin Invest 101, 1614-1622. Spergel, J.M., and Paller, A.S. (2003). Atopic dermatitis and The atopic march. J Allergy Clin Immunol 112, S118-127. Strickland, I., Hauk, P.J., Trumble, A.E., Picker, L.J., and Leung, D.Y. (1999). Evidence for superantigen involvement in skin homing of T cells in atopic dermatitis. J Invest Dermatol 112, 249-253. Sudo, N., Sawamura, S., Tanaka, K., Aiba, Y., Kubo, C., and Koga, Y. (1997). The requirement of intestinal bacterial flora for The development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 159, 1739-1745. Suzuki, Y., Adachi, Y., Ohno, N., and Yadomae, T. (2001). Th1/Th2-Balancing immunomodulating activity of gel-forming (1-->3)-beta-glucans from fungi. Biol Pharm Bull 24, 811-819. Trautmann, A., Akdis, M., Kleemann, D., Altznauer, F., Simon, H.U., Graeve, T., Noll, M., Brocker, E.B., Blaser, K., and Akdis, C.A. (2000). T cell-mediated Fas-induced keratinocyte apoptosis plays a key paThogenetic role in eczematous dermatitis. J Clin Invest 106, 25-35. Tzianabos, A.O. (2000). Polysaccharide immunomodulators as Therapeutic agents: structural aspects and biologic function. Clin Microbiol Rev 13, 523-533. Verhagen, J., Akdis, M., Traidl-Hoffmann, C., Schmid-Grendelmeier, P., Hijnen, D., Knol, E.F., Behrendt, H., Blaser, K., and Akdis, C.A. (2006). Absence of T-regulatory cell expression and function in atopic dermatitis skin. J Allergy Clin Immunol 117, 176-183. Volman, J.J., Ramakers, J.D., and Plat, J. (2008). Dietary modulation of immune function by beta-glucans. Physiol Behav 94, 276-284. Wakita, H., Sakamoto, T., Tokura, Y., and Takigawa, M. (1994). E-selectin and vascular cell adhesion molecule-1 as critical adhesion molecules for infiltration of T lymphocytes and eosinophils in atopic dermatitis. J Cutan PaThol 21, 33-39. Wang, Y.C., Yu, R.C., and Chou, C.C. (2006). Antioxidative activities of soymilk fermented wiTh lactic acid bacteria and bifidobacteria. Food Microbiol 23, 128-135. Watanabe, S., Narisawa, Y., Arase, S., Okamatsu, H., Ikenaga, T., Tajiri, Y., and Kumemura, M. (2003). Differences in fecal microflora between patients wiTh atopic dermatitis and healThy control subjects. J Allergy Clin Immunol 111, 587-591. Wedi, B., Raap, U., and Kapp, A. (1999). Significant delay of apoptosis and Fas resistance in eosinophils of subjects wiTh intrinsic and extrinsic type of atopic dermatitis. Int Arch Allergy Immunol 118, 234-235. Werfel, T. (2009). The role of leukocytes, keratinocytes, and allergen-specific IgE in The development of atopic dermatitis. J Invest Dermatol 129, 1878-1891. Whitacre, C.C., Gienapp, I.E., Orosz, C.G., and Bitar, D.M. (1991). Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J Immunol 147, 2155-2163. Williams, D.L. (1997). Overview of (1-->3)-beta-D-glucan immunobiology. Mediators Inflamm 6, 247-250. Williams, H. (2002). New treatments for atopic dermatitis. BMJ 324, 1533-1534. Wood, B. J. B., 1998, Protein-rich foods based on fermented vegetable. In Wood, B. J. B., (ed.), “Microbiology of fermented foods ”, vol. 2, Blackie A & P, London, pp. 484-504. Yamauchi, F., Suetsuna, K., 1993, Immunological effects of dietary peptide derived from soybean protein. J. Nutr. Biochem. 4:450-457. Young, S.H., Ye, J., Frazer, D.G., Shi, X., and Castranova, V. (2001). Molecular mechanism of tumor necrosis factor-alpha production in 1-->3-beta-glucan (zymosan)-activated macrophages. J Biol Chem 276, 20781-20787. Zekovic, D.B., Kwiatkowski, S., Vrvic, M.M., Jakovljevic, D., and Moran, C.A. (2005). Natural and modified (1-->3)-beta-D-glucans in healTh promotion and disease alleviation. Crit Rev Biotechnol 25, 205-230. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/8622 | - |
dc.description.abstract | 腸道是人體重要的免疫系統,在腸道的淋巴組織(Gut-associated lymphoid tissue, GALT)約占身體免疫系統的70%。腸道細菌的刺激對於腸道免疫系統的調節是相當重要的,其中像是益生菌,可以改變宿主腸道菌叢而產生有益健康效果,並可以在大腸中利用小腸無法消化吸收的物質(益生物質)為食物,例如:β聚糖,發酵產生有益腸道之物質並抑制壞菌生長。豆科植物Legume特別是指帶有豆莢且有整齊排列種子包裹在內的植物,像是蠶豆、豌豆等。豆類的營養價值高,富含有纖維素、脂質、礦物質及維他命等,其中大豆更含有大量的必需胺基酸,是很好的蛋白質來源。發酵作用可分解大分子物質、增加易消化性、增進生物可利用率,進而提高營養價值;發酵物不僅易於消化吸收,還可消除自由基、抗老化,增強抵抗力。本實驗主要的研究目的:是想去探討酵母菌(Saccharomyces cerevisiae)以及利用酵母菌進行豆類發酵後的產物對實驗性異位性皮膚炎老鼠模式的免疫調節作用。已有許多文獻指出:食用以酵母菌、乳酸菌發酵的食品是具有抗氧化、抗癌以及增加免疫力等功效,此外,韓國的一種傳統的豆類發酵食品Chungkukjang在文獻中提到對於過敏反應是有益的,特別像是氣喘和異位性皮膚炎。首先,利用異位性皮膚炎的老鼠動物模式來進行實驗,結果顯示,不論在誘導期或是作用期的異位性皮膚炎,餵食豆類發酵產物(SCLFP)的老鼠,所分泌的細胞激素會傾向TH1的反應,以及顯著提升抗發炎細胞IL-10的量,在細胞增生指數則是呈現顯著被抑制的結果。為了增強免疫反應的差異,在藥劑的部分添加了金黃色葡萄球菌腸毒素B,在外觀以及組織切片的結果,都可以看到餵食豆類發酵產物在異位性皮膚炎的症狀上都有明顯的改善。最後,去探討建立口服耐受性對異位性皮膚炎的影響,結果顯示,建立口服耐受性是可以成功降低對於外來物質容易產生敏感性的免疫反應,進一步去影響異位性皮膚炎的免疫調節。綜合以上,我們推測餵食豆類發酵產物可以去調節TH1與TH2之間的平衡,此外,對於異位性皮膚炎症狀的改善,推測可能是與誘導調節性T細胞的產生有關。 | zh_TW |
dc.description.abstract | The gastrointestinal tract is the important immunity system and the functions as a barrier against antigens from microorganisms and food. The generation of immunophysiologic regulation in the gut depends on the establishment of indigenous microflora. Probiotics are defined as live bacterial preparations with clinically documented health effects in humans. Legumes are plants that have pods with tidy rows of seeds inside includes beans, peas, lentils and peanuts. Pulses contain significant amounts of crude fibre, lipids, minerals and vitamins. Soy contains significant amounts of all the essential amino acids for humans and so is a good source of protein. The fermentation process helps not only in improving the organoleptic quality of legumes but also enhances nutritional quality. Fermentation is an important area of research, which entails the ability to hydrolyze soy protein into smaller peptides. In addition, previous study demonstrated that a Korean traditional fermented soybean food: Chungkukjang may be beneficial for several allergic conditions such as asthma and atopic dermatitis. In this study, we use an experimental atopic dermatitis animal model to investigate immunomodulation effect of saccharomyces cerevisiae and it’s legume fermented product. Our result showed that in mice under induction or effection phase of atopic dermatitis, the administration of saccharomyces cerevisiae legume fermented product (SCLFP) can induce Th1 specific immune response and increase cytokine IL-10. Furthermore, SCLFP-administration can improve skin lesions. On the other hand, SCLFP may enhance oral tolerance that decreased allergic response. We hypothesized that the effect of SCLFP on atopic dermatitis may be related to the induction of regulatory T cells. | en |
dc.description.provenance | Made available in DSpace on 2021-05-20T19:59:01Z (GMT). No. of bitstreams: 1 ntu-99-R97450006-1.pdf: 4399013 bytes, checksum: 0ad89e1d09b7b84740c821f6594dc340 (MD5) Previous issue date: 2010 | en |
dc.description.tableofcontents | 目錄
中文摘要 I 英文摘要 II 目錄 III 圖目錄………………………………………………………………………………….V 第一章 文獻回顧 1 第一節 飲食影響免疫調節 1 第二節 豆科植物(Legume) 3 第三節 豆類的營養價值及用途 4 第四節 直接食用豆類的問題 5 第五節 發酵豆類食品之營養與機能 6 第六節 釀酒酵母(Saccharomyces cerevisiae) 7 第七節 過敏簡介 9 第八節 異位性皮膚炎(atopic dermatitis) 9 第九節 金黃色葡萄球菌與異位性皮膚炎的關係 12 第十節 口服耐受性與異位性皮膚炎的關係 13 第十一節 研究目的與實驗設計 14 第二章 實驗材料與方法 15 第一節 實驗動物小鼠 15 第二節 建立異位性皮膚炎老鼠動物模式(Atopic dermatitis model) 15 第三節 豆類發酵產物的製備 16 第四節 熱致死酵母菌(Saccharomyces cerevisiae) 的製備 16 第五節 老鼠食道插管餵食 17 第六節 異位性皮膚炎之誘導期實驗設計 17 第七節 異位性皮膚炎之作用期實驗設計 17 第八節 作用期的異位性皮膚炎老鼠模式加上金黃色葡萄球菌腸毒素B (Staphylococcal enterotoxin B)實驗設計 18 第九節 建立口服耐受性(oral tolerance)對異位性皮膚炎之作用期實驗設計 19 第十節 老鼠血清特異性抗體(specific antibody)的偵測 19 第十一節 老鼠脾臟(Spleen)、腸繫膜淋巴結(Mesenteric lymph node)、浸潤淋巴結(Draing lymph node)細胞培養及刺激的方法 20 第十二節 細胞增生(cell proliferation)的偵測 22 第十三節 細胞激素(cytokine)的偵測 22 第十四節 組織化學染色(H&E stain) 23 第十五節 組織化學染色表皮厚度加以量化 23 第十六節 組織化學染色發炎細胞Eosinphils的計數 23 第十七節 統計分析 24 第三章 實驗結果 24 第一節 偵測誘導期的浸潤淋巴結以OVA刺激後分泌細胞激素的情形 24 第二節 偵測誘導期的浸潤淋巴結以OVA刺激後細胞增生的情形 25 第三節 偵測作用期的老鼠血清中抗OVA特異性抗體 26 第四節 作用期的異位性皮膚炎老鼠模式各組在外觀上的差異 27 第五節 偵測作用期的脾臟細胞及腸繫膜淋巴結細胞以OVA刺激後分泌細胞激素的情形 27 第六節 偵測作用期的脾臟細胞及腸繫膜淋巴結以OVA刺激後細胞增生的情形 29 第七節 作用期的異位性皮膚炎老鼠模式加上金黃色葡萄球菌腸毒素B (Staphylococcal enterotoxin B) 各組在外觀上的差異 29 第八節 作用期的異位性皮膚炎老鼠模式加上金黃色葡萄球菌腸毒素B (Staphylococcal enterotoxin B) H&E stain在各組皮膚上的差異 30 第九節 作用期的異位性皮膚炎老鼠模式加上金黃色葡萄球菌腸毒素B (Staphylococcal enterotoxin B) H&E stain在各組皮膚上的差異加以量化統計 31 第十節 作用期的異位性皮膚炎老鼠模式加上金黃色葡萄球菌腸毒素B (Staphylococcal enterotoxin B)在各組皮膚上發炎細胞Eosinophils浸潤的差異加以量化統計 32 第十一節 作用期的異位性皮膚炎老鼠模式加上金黃色葡萄球菌腸毒素B (Staphylococcal enterotoxin B)體重的變化 32 第十二節 建立口服耐受性在作用期的異位性皮膚炎老鼠模式各組在外觀上的差異 33 第十三節 建立口服耐受性在偵測作用期的老鼠血清中抗OVA特異性抗體 34 第十四節 建立口服耐受性在偵測作用期的脾臟細胞及腸繫膜淋巴結細胞以OVA刺激後分泌細胞激素的情形 35 第十五節 建立口服耐受性在偵測作用期的脾臟細胞及腸繫膜淋巴結以OVA刺激後細胞增生的情形 36 第四章 討論 37 第五章 參考文獻 44 圖目錄 圖一、異位性皮膚炎的建立 61 圖二、異位性皮膚炎之誘導期實驗設計 62 圖三、偵測誘導期的浸潤淋巴結以OVA刺激後分泌細胞激素的情形 63 圖四、偵測誘導期的浸潤淋巴結以OVA刺激後細胞增生的情形 64 圖五、異位性皮膚炎之作用期實驗設計 65 圖六、偵測作用期的老鼠血清中抗OVA特異性抗體 66 圖七、作用期的異位性皮膚炎老鼠模式各組在外觀上的差異 67 圖八、偵測作用期的脾臟細胞以OVA刺激後分泌細胞激素的情形 68 圖九、偵測作用期的腸繫膜淋巴結細胞以OVA刺激後分泌細胞激素的情形 69 圖十、偵測作用期的脾臟細胞及腸繫膜淋巴結以OVA刺激後細胞增生的情形 70 圖十一、作用期的異位性皮膚炎老鼠模式加上金黃色葡萄球菌腸毒素B (Staphylococcal enterotoxin B) 各組在外觀上的差異 71 圖十二、作用期的異位性皮膚炎老鼠模式加上金黃色葡萄球菌腸毒素B (Staphylococcal enterotoxin B) H&E stain在各組皮膚上的差異 72 圖十三、作用期的異位性皮膚炎老鼠模式加上金黃色葡萄球菌腸毒素B (Staphylococcal enterotoxin B) H&E stain在各組皮膚上的差異加以量化統計 73 圖十四、作用期的異位性皮膚炎老鼠模式加上金黃色葡萄球菌腸毒素B (Staphylococcal enterotoxin B)在各組皮膚上發炎細胞Eosinophils浸潤的差異加以量化統計 74 圖十五、作用期的異位性皮膚炎老鼠模式加上金黃色葡萄球菌腸毒素B (Staphylococcal enterotoxin B)體重的變化 75 圖十六、探討建立口服耐受性(oral tolerance)對異位性皮膚炎之作用期實驗設計 76 圖十七、建立口服耐受性在作用期的異位性皮膚炎老鼠模式各組在外觀上的差異 77 圖十八、建立口服耐受性在偵測作用期的老鼠血清中抗OVA特異性抗體 78 圖十九、建立口服耐受性在偵測作用期的脾臟細胞以OVA刺激後分泌細胞激素的情形 79 圖二十、建立口服耐受性在偵測作用期的腸繫膜淋巴結細胞以OVA刺激後分泌細胞激素的情形 80 圖二十一、建立口服耐受性在偵測作用期的脾臟細胞及腸繫膜淋巴結以OVA刺激後細胞增生的情形 81 附表、附圖 82 | |
dc.language.iso | zh-TW | |
dc.title | 探討利用酵母菌進行豆類發酵後的產物對實驗性異位性皮膚炎老鼠模式的免疫調節作用 | zh_TW |
dc.title | Immunomodulatory effect of a legume-based fermented product by Saccharomyces cerevisiae in experimental atopic dermatitis | en |
dc.type | Thesis | |
dc.date.schoolyear | 98-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 顧家綺(Chia-Chi Ku),繆希椿(S.-C. Miaw),王莉芳(Li-Fang Wang) | |
dc.subject.keyword | 異位性皮膚炎,豆類發酵產物,釀酒酵母, | zh_TW |
dc.subject.keyword | atopic dermatitis,legume-based fermented product,Saccharomyces cerevisiae, | en |
dc.relation.page | 90 | |
dc.rights.note | 同意授權(全球公開) | |
dc.date.accepted | 2010-07-01 | |
dc.contributor.author-college | 牙醫專業學院 | zh_TW |
dc.contributor.author-dept | 口腔生物科學研究所 | zh_TW |
顯示於系所單位: | 口腔生物科學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-99-1.pdf | 4.3 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。